Iain Cameron is Professor of Obstetrics and Gynaecology and Dean of the Faculty of Medicine at the University of Southampton. After graduating in Medicine at the University of Edinburgh, he underwent postgraduate clinical and research training in obstetrics and gynaecology, and reproductive medicine, in Edinburgh, Melbourne and Cambridge.
He held the Regius Chair of Obstetrics and Gynaecology at the University of Glasgow from 1993 and moved to Southampton in 1999. His main clinical and research interests are reproductive endocrinology, the treatment of sub-fertility and investigation of the impact of the maternal environment on early pregnancy.
Iain is a member of the Scientific and Ethical Review Group, Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organisation; a member of the Executive Committee, and Chair of the Medical Staffing Sub-Committee, Medical Schools Council; and a member of the Boards of the UK Clinical Research Collaboration (UKCRC) and the UK Research Integrity Office (UKRIO).
Cyrus Cooper is Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Musculoskeletal Science at the University of Oxford. Professor Cooper graduated from the University of Cambridge and St Bartholomew's Hospital, London in 1980, and completed his residency in 1985 at the Southampton University Hospitals. In 1990, he won an MRC Travelling Fellowship to the Mayo Clinic, USA, where he continued his research in osteoporosis. He returned to the UK in 1992 to take up a position as Senior Lecturer in Rheumatology and MRC Senior Clinical Scientist. He was promoted to the foundation Chair in Rheumatology at the University of Southampton in 1997 while continuing as an MRC Senior Clinical Scientist at the MRC Environmental Epidemiology Unit. In 2003, he was appointed Director of the MRC Epidemiology Resource Centre, University of Southampton. In 2010, this was reconfigured as the MRC Lifecourse Epidemiology Unit and quinquennial funding extended to 2015.
Professor Cooper leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. His key research contributions have been: (1) discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; (2) demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; (3) characterisation of the definition and incidence rates of vertebral fractures; and (4) leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture.
Professor Cooper is immediate past-President of the Bone Research Society of Great Britain and Chairman of the Committee of Scientific Advisors, International Osteoporosis Foundation. He has previously served as Chairman of the National Osteoporosis Society and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups. He is Chair of the MRC Population Health Sciences Research Network; Associate Director of Research at the University of Southampton Medical School; and Associate Editor of Osteoporosis International. He has published extensively (over 600 research papers) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass.
Professor John Holloway is Associate Dean Research, with responsibility for directing the Faculty's research strategy. He also holds the chair of Allergy and Respiratory Genetics in the Human Development and Health Academic Unit.
John leads the Respiratory Genetics Group, undertaking a programme of research into the genetic basis of allergy, asthma and other respiratory diseases. He was part of the team that identified the first asthma susceptibility gene through positional cloning (ADAM33), and he continues to contribute extensively to the understanding of the genetic basis of asthma susceptibility. More recently his work has focused on the genetic and epigenetic basis for the role of early life in determining susceptibility to allergic disease. He has published more than 100 peer-reviewed papers and 50 contributed reviews/book chapters.
John is vice-chair of the BMBS COST Action network: Developmental origins of Chronic Lung Disease and he is a member of the Asthma UK Research Review Panel. He currently serves on the editorial board of Allergy (European Journal of Allergy and Clinical Immunology) and has previously been an associate editor for Clinical & Experimental Allergy. John served as a member of Council for the British Society of Allergy and Clinical Immunology and is currently a Faculty Member for the Respiratory Pharmacology Section of Faculty of 1000.
As well as his on-going research, John also teaches clinical pharmacology and molecular cell biology on the Bachelor of Medicine programme and genetics on the MSc Allergy.
Information to follow
Professor David Wilson is Associate Dean for Internationalisation in the Faculty of Medicine and Professor of Human Developmental Genetics.
After graduating in Physiology at University of Oxford and Medicine at the University of Newcastle, he underwent postgraduate training in Internal Medicine, Paediatrics and Genetics in Newcastle.
David’s research training was centred in Newcastle and Amsterdam and focused on developmental genetics and cardiogenesis. Current research interests include the genetic basis for human cardiac maldevelopment (in particular hypoplastic left heart syndrome) and cardiac stem cells. He has strong links with the cardiac congenital service and is a board member of the Children’s Hospital Southampton for research.
In addition to running his research group, David continues to teach genetics on the Bachelor of Medicine course and PhD programmes. He is very enthusiastic in his support for international students.
As part of the University’s internationalisation strategy, David has established links with key institutions in Latin America to facilitate collaborative research and is active in recruiting international postgraduate students to Southampton.
Salim Khakoo is the Associate Dean for Enterprise. He currently holds the Chair in Hepatology in The Clinical and Experimental Sciences Academic Unit and is Director of Biomedical Research (IFLS). He qualified from Guy’s Hospital, London in 1988 and trained in Gastroenterology and Hepatology.
His research interest in viral hepatitis and natural killer cell biology developed at The Royal Free Hospital, at Stanford, USA and then subsequently through MRC clinician scientist and Wellcome Trust Senior fellowship awards. He was the first person to describe the role of natural killer cells in hepatitis C virus infection (Science 2004) and was the UK lead for the consortium describing the role of IL28B in hepatitis C virus infection (Nature 2009). He currently runs an active hepatology and immunology research group focusing on natural killer cells and their role in the molecular recognition of virally infected cells and cancer.
Salim is the secretary of The Association of Physicians, a member of the scientific advisory board for The Children’s Liver Disease Foundation, a member of The Faculty of 1000 (Gastroenterology section) and an advisory member for the National and Kapodistrian University, Athens. He has previously served on the British Society for Gastroenterology Liver Section.
Adrian joined the University in June 2011 as the Operational Manager for the National Institute for Health Research Design Service. Prior to that he held various senior leadership roles within the NHS including an executive director role within an east London NHS Trust, Director of Policy and Standards at the UKCC (forerunner of the Nursing & Midwifery Council), and Clinical Director for Multi-Channel Services at NHS Direct. Adrian has worked with the Department of Health in developing various health policy initiatives and in setting up the NHS Choices. He has extensive experience in leading and developing health care strategies and managing complex organisations. Adrian is an external assessor for the NICE-NHS Evidence accreditation scheme.
Chris, a CIMA-qualified accountant joined the University in 2005, heading the Finance team for the Faculty of Medicine, Health and Life Sciences, as it was known. He now leads the Faculty of Medine's Finance team, with responsibilities including pre and post-award research financial administration and non-research financial accounting.